25 related articles for article (PubMed ID: 4623599)
1. Zuclopenthixol dihydrochloride for schizophrenia.
Bryan EJ; Purcell MA; Kumar A
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD005474. PubMed ID: 29144549
[TBL] [Abstract][Full Text] [Related]
2. A clinical evaluation of clopenthixol.
Yaryura-Tobias JA; Wolpert A; White L; Agola P; Merlis S
Curr Ther Res Clin Exp; 1970 May; 12(5):271-9. PubMed ID: 4986242
[No Abstract] [Full Text] [Related]
3. Clinical evaluation of thiothixene in acute newly admitted schizophrenic patients.
Ngui PW; Teo SH
Singapore Med J; 1971 Aug; 12(4):227-32. PubMed ID: 5129906
[No Abstract] [Full Text] [Related]
4. Thiothixene in schizophrenic psychoses.
Vinar O; Taussigová D; Bastecký J
Act Nerv Super (Praha); 1971; 13(3):174-7. PubMed ID: 4939830
[No Abstract] [Full Text] [Related]
5. Thiothixene. Its range of therapeutic activity.
Oliveros RT; Ban TA; Lehmann HE; Sterlin C; Saxena BM
Int Z Klin Pharmakol Ther Toxikol; 1970 Jan; 3(1):26-9. PubMed ID: 4909376
[No Abstract] [Full Text] [Related]
6. Clopenthixol in schizophrenia. Comparison of two groups of patients treated by the same drug.
Vinar O; Bastecký J; Taussigová D; Formánková M; Růzicka S
Act Nerv Super (Praha); 1967 Nov; 9(4):401-4. PubMed ID: 4889074
[No Abstract] [Full Text] [Related]
7. The place of thiothixene among the thioxanthenes.
Sterlin C; Ban TA; Jarrold L
Curr Ther Res Clin Exp; 1972 Apr; 14(4):205-14. PubMed ID: 4623599
[No Abstract] [Full Text] [Related]
8. Drug treatment in schizophrenia.
Ban TA
Can Psychiatr Assoc J; 1971 Dec; 16(6):473-85. PubMed ID: 4947634
[No Abstract] [Full Text] [Related]
9. [The cardiovascular effects of neuroleptics based on current knowledge].
Pieschl D
Nervenarzt; 1973 Apr; 44(4):212-5. PubMed ID: 4573587
[No Abstract] [Full Text] [Related]
10. Chemical, pharmacological, and metabolic considerations on thiothixene. Introduction: chemical and pharmacological relationship of thioxanthenes and phenothiazines.
Weissman A
Adv Biochem Psychopharmacol; 1974; 9(0):471-80. PubMed ID: 4151768
[No Abstract] [Full Text] [Related]
11. [The factors influencing the effectiveness of therapy in schizophrenia and the principles of patient selection for a comparative evaluation of the results of treatment (a survey of the literature)].
Karimov RK
Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):612-9. PubMed ID: 4574524
[No Abstract] [Full Text] [Related]
12. Megavitamin B-3 therapy for schizophrenia.
Hoffer A
Can Psychiatr Assoc J; 1971 Dec; 16(6):499-504. PubMed ID: 4947171
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
